Nestle SA said it would be delivering baby formula to the United States from its plants in Switzerland and the Netherlands to help ease up the shortage in U.S. markets. The company announced on Tuesday, May 17, that it will supply Alfamino and Gerber baby formula brands to America.
As per Reuters, parents are panicking as they can no longer find any infant milk formulas in supermarkets as the shelves are always empty these days. The shortage started when Abbott Laboratories, a leading medical devices and health care company in the U.S., recalled several types of its popular baby formula brands, including Similac, EleCare, and Alimnetum.
The milk formula manufacturer issued a recall on the said brands in February following the deaths of two infants who contracted a rare kind of infection. The U.S. Food and Drug Administration (USFDA) carried out an investigation on Abbott and discovered traces of the pathogen Cronobacter sakazakii in its plant in Michigan.
Abbott explained that the said pathogen may have been found in environmental testing during the investigation, but it has not been linked to any infant illness. It also stated that no distributed product was ever tested positive for the presence of any bacteria such as Salmonella Newport and Cronobacter sakasakii, based on the tests. But still, the company still issued the recall due to the complaints it received.
"While Abbott's testing of finished product detected no pathogens, we are taking action by recalling the powder formula manufactured in this facility with an expiration of April 1, 2022, or later," Abbott stated in a press release at that time. "No Abbott liquid formulas, powder formulas, or nutrition products from other facilities are impacted by the recall."
As this incident led to the formula shortage, Nestle will help alleviate the problem by bringing its infant milk formula products to the U.S. the company will be rushing the deliveries as the shortage has now reached the nationwide level.
"We prioritized these products because they serve a critical medical purpose as they are for babies with cow's milk protein allergies," Nestle stated. "Both products (Alfamino and Gerber) were already being imported but we moved shipments up and rushed via air to help fill immediate needs."
Meanwhile, Reckitt Benckiser is also increasing its production of infant formula by 30% to help combat the shortage. It has also upped the frequency of its deliveries to stores and groceries in the U.S.


Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Dollar Struggles as Markets Eye Key Central Bank Decisions and Global Rate Outlooks
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
South Korea Warns Weak Won Could Push Inflation Higher in 2025
Oil Prices Slip in Asia as 2026 Supply Glut Fears and Russia-Ukraine Talks Weigh on Markets
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Gold and Silver Prices Dip as Markets Await Key U.S. Economic Data
Singapore Growth Outlook Brightens for 2025 as Economists Flag AI and Geopolitical Risks
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
Japan Exports to U.S. Rebound in November as Tariff Impact Eases, Boosting BOJ Rate Hike Expectations
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 



